SOLESENCE, INC. SLSN
Nasdaq · XNAS · stock · Perfumes, Cosmetics & Other Toilet Preparations · website · IPO 1997-11-28
SOLESENCE, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $62.1M | $52.3M | $37.3M | $37.3M | $29.5M |
| Gross profit | $16.1M | $16.2M | $7.8M | $8.4M | $8.7M |
| R&D expense | $4.1M | $3.8M | $3.8M | $3.0M | $2.2M |
| SG&A expense | $10.4M | $7.2M | $7.5M | $7.6M | $3.9M |
| Operating income | $1.6M | $5.1M | -$3.5M | -$2.3M | $2.6M |
| Interest expense | — | — | $838,000 | $382,000 | $1.2M |
| Income tax | $73,000 | $227,000 | $6,000 | -$17,000 | $37,000 |
| Net income | $1.8M | $4.2M | -$4.4M | -$2.6M | $2.3M |
| EPS (diluted) | $0.02 | $0.07 | $-0.09 | $-0.05 | $0.05 |
| Operating cash flow | -$8.6M | $2.0M | -$2.0M | -$1.6M | $2.3M |
| Free cash flow | — | -$2.6M | -$3.1M | -$4.5M | $447,000 |
| Cash & equivalents | $1.3M | $1.4M | $1.7M | $2.2M | $657,000 |
| Inventory | $18.5M | $20.3M | $10.0M | $8.8M | $6.1M |
| Total assets | $50.1M | $50.0M | $32.9M | $33.6M | $28.4M |
| Shareholders' equity | $17.6M | $14.9M | $1.9M | $5.6M | $7.5M |
Source: SEC EDGAR filings · CIK 0000883107 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.